August Moretti

August Moretti is the Chief Financial Officer of 4D Molecular Therapeutics, a publicly held gene therapy company. Prior to this role, he served as CFO of Assertio Therapeutics, a publicly held specialty pharmaceutical company, and before that he was CFO of Alexza Pharmaceuticals, a publicly held life science company. Mr. Moretti began his career practicing corporate and securities law. He received his JD degree from Harvard Law School and a Bachelor’s degree in Economics from Princeton University.